We found that DCs, loaded with PDL1-Vax, induced anti-PD-L1 antibody and T cell responses in immunized mice and that PD-L1-specific CTLs had cytolytic activities against PD-L1+ tumor cells. The gene discussed is CD274; the disease is neoplasm.